The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Estimated Growth In Market Size Of The Intranasal Corticosteroids Market During 2026–2030?
The market for intranasal corticosteroids has experienced substantial growth in recent years. Its valuation is set to increase from $6.78 billion in 2025 to $7.31 billion in 2026, advancing at a compound annual growth rate (CAGR) of 7.8%. The expansion observed in prior periods is linked to factors including limited awareness of intranasal corticosteroids, reliance on hospital pharmacies for drug distribution, growing incidence of nasal allergies, preference for conventional treatment methods, and restricted online pharmacy access.
The intranasal corticosteroids market size is anticipated to expand significantly over the next few years, projected to reach $9.74 billion in 2030, growing at a compound annual growth rate (CAGR) of 7.4%. This growth during the forecast period is primarily driven by factors such as increasing healthcare awareness, the expansion of retail and online pharmacies, a rising incidence of chronic rhinitis and nasal polyps, the adoption of combination therapies, and the development of patient-friendly spray devices. Concurrently, major trends expected in this period include the rising prevalence of allergic rhinitis and other nasal disorders, increased adoption of prescription intranasal corticosteroids, a surge in over-the-counter intranasal corticosteroid use, the widening of hospital and homecare distribution channels, and a heightened focus on patient-centric treatment and ease of administration.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25799&type=smp
What Market Drivers Are Helping Shape The Intranasal Corticosteroids Market Expansion?
The anticipated expansion of the intranasal corticosteroids market is linked to the rising occurrence of allergic rhinitis. Allergic rhinitis, an allergic response, leads to inflammation within the nasal passages, commonly provoked by airborne allergens like pollen, dust mites, mold, or pet dander. This increase in allergic rhinitis cases largely stems from escalating environmental pollution, which exposes individuals to airborne allergens and irritants, thus initiating allergic reactions in the nasal passages. Intranasal corticosteroids assist in managing allergic rhinitis by diminishing inflammation in the nasal passages, thereby alleviating symptoms like sneezing, congestion, and a runny nose. For example, data from October 2023, reported by the US-based biomedical library, the National Library of Medicine, indicates that allergic rhinitis impacts over 400 million individuals globally, with adult prevalence rates ranging from 10% to 30% and exceeding 40% in children. Consequently, the expanding prevalence of allergic rhinitis is a key factor propelling the intranasal corticosteroid market.
What Segment Categories Are Evaluated In The Intranasal Corticosteroids Market Study?
The intranasal corticosteroids market covered in this report is segmented –
1) By Drug Types: Prescribed Drugs, Over-The-Counter Drugs
2) By Application: Allergic Rhinitis, Nasal Polyps, Sinusitis, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channel
4) By End User: Hospitals, Clinics, Homecare, Healthcare Providers
Subsegments:
1) By Prescribed Drugs: Fluticasone Propionate, Mometasone Furoate, Budesonide, Beclomethasone Dipropionate, Ciclesonide
2) By Over-The-Counter Drugs: Triamcinolone Acetonide, Fluticasone Furoate, Budesonide Over-The-Counter Drugs
What Trends Are Impacting The Intranasal Corticosteroids Market?
Leading companies in the intranasal corticosteroids market are concentrating on developing advanced formulations, such as nasal sprays, to optimize targeted medication delivery and enhance patient adherence. Nasal sprays are liquid drugs delivered directly into the nose via a spray nozzle to address conditions including allergies, congestion, or inflammation. These enable swift drug absorption through the nasal mucosa, providing rapid relief with minimal systemic side effects. For example, in March 2024, OptiNose Inc., a US-based pharmaceutical entity, obtained approval from the U.S. Food and Drug Administration (FDA) for XHANCE, which is the first and only treatment specifically approved for adults experiencing chronic rhinosinusitis (CRS) without nasal polyps. This nasal spray incorporates a distinctive exhalation delivery system that allows the medication to reach deep within the nasal cavity, effectively treating CRS in adults, with or without nasal polyps. Each spray dispenses 93 mcg of fluticasone propionate, and the device operates by having the user exhale into a mouthpiece while simultaneously activating the spray into the nostril, ensuring accurate delivery and better symptom alleviation.
Which Companies Form The Competitive Landscape Of The Intranasal Corticosteroids Market?
Major companies operating in the intranasal corticosteroids market are GlaxoSmithKline plc, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Haleon plc, Intas Pharmaceuticals Limited, Organon Pharma (UK) Limited, Sun Pharmaceutical Industries Ltd., Apotex Inc., Perrigo Company plc, Aurobindo Pharma Limited, Cipla Ltd., Hikma Pharmaceuticals plc, Zydus Lifesciences Ltd., Glenmark Pharmaceuticals Limited, OptiNose US Inc., Taro Pharmaceutical Industries Ltd., Maya Biotech Private Limited, AdvaCare Pharma USA, Lupin Ltd., Xenone Healthcare Private Limited.
Access The Complete Intranasal Corticosteroids Market Report:
https://www.thebusinessresearchcompany.com/report/intranasal-corticosteroids-global-market-report
Which Region Accounts For The Highest Share Of The Intranasal Corticosteroids Market?
North America was the largest region in the intranasal corticosteroids market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intranasal corticosteroids market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Intranasal Corticosteroids Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=25799&type=smp
Browse Through More Reports Similar to the Global Intranasal Corticosteroids Market 2026, By The Business Research Company
Internal Nasal Dilators Market Report 2026
https://www.thebusinessresearchcompany.com/report/internal-nasal-dilators-global-market-report
Corticosteroid Market Report 2026
https://www.thebusinessresearchcompany.com/report/corticosteroid-global-market-report
Intranasal Drug Delivery Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model